Just reported
From NRC Health's results release of October 27, 2026; its quarterly report has since been filed.
Actual
$38.4M
+11% y/y
+8.5% q/q
Guided
—
No guide given
Actual
$0.21
+17% y/y
Guided
—
No guide given
Actual
$8.9M
+15% y/y
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →The themes NRC Health is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Built from NRC Health’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
$26.52-0.6%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 4, 2026
Grade C
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 41 quarters of NRC Health’s grade history. The other 39 go back to November 2016.